Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

    Contemporary analyses focused on a limited number of clinical and molecular biomarkers have been unable to accurately predict clinical outcomes in pancreatic ductal adenocarcinoma. Here we describe a precision...

    Arsen Osipov, Ognjen Nikolic, Arkadiusz Gertych, Sarah Parker in Nature Cancer (2024)

  2. Article

    Open Access

    CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

    Even acknowledging the game-changing results achieved in the treatment of metastatic melanoma with the use of immune checkpoint inhibitors (ICI), a large proportion of patients (40–60%) still fail to respond o...

    Lidia Giraudo, Giulia Cattaneo in Journal of Experimental & Clinical Cancer … (2023)

  3. No Access

    Article

    Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic Cancer

    Portal vein and superior mesenteric vein thrombosis (PVT/SMVT) are potentially morbid complications of radiation dose–escalated local therapy for pancreatic cancer. We retrospectively reviewed records for pati...

    Alicia C. Smart, Andrzej Niemierko, Jennifer Y. Wo in Journal of Gastrointestinal Surgery (2023)

  4. Article

    Open Access

    Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

    The poor efficacy of chimeric antigen receptor T-cell therapy (CAR T) for solid tumors is due to insufficient CAR T cell tumor infiltration, in vivo expansion, persistence, and effector function, as well as ex...

    Yufeng Wang, David L. Drum, Ruochuan Sun, Yida Zhang, Feng Chen in Nature Communications (2023)

  5. No Access

    Article

    Neoadjuvant therapy for pancreatic cancer

    Patients with localized pancreatic ductal adenocarcinoma (PDAC) are best treated with surgical resection of the primary tumour and systemic chemotherapy, which provides considerably longer overall survival (OS...

    Christoph Springfeld, Cristina R. Ferrone in Nature Reviews Clinical Oncology (2023)

  6. Article

    SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers

    Adult liver malignancies, including intrahepatic cholangiocarcinoma and hepatocellular carcinoma, are the second leading cause of cancer-related deaths worldwide. Most individuals are treated with either combi...

    Lei Shi, William Shen, Mindy I. Davis, Ke Kong, Phuong Vu, Supriya K. Saha in Nature Cancer (2023)

  7. No Access

    Article

    Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

    Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal and treatment-refractory cancer. Molecular stratification in pancreatic cancer remains rudimentary and does not yet inform clinical management or ther...

    William L. Hwang, Karthik A. Jagadeesh, Jimmy A. Guo, Hannah I. Hoffman in Nature Genetics (2022)

  8. No Access

    Article

    Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy

    Dynamic survival data based on time already survived are lacking for resected borderline resectable/locally advanced (BR/LA) pancreatic ductal adenocarcinoma (PDAC) patients who received total neoadjuvant ther...

    Theodoros Michelakos, Yurie Sekigami in Journal of Gastrointestinal Surgery (2021)

  9. No Access

    Article

    Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival

    The survival benefit of negative margins for hepatocellular carcinoma (HCC) has been demonstrated. However, there is no consensus regarding the optimal resection margin width. We assessed the impact of hepatic...

    Theodoros Michelakos, Filippos Kontos in Journal of Gastrointestinal Surgery (2021)

  10. No Access

    Article

    Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study

    Imaging is central to the diagnosis and management of Pancreatic Ductal Adenocarcinoma (PDAC). This study evaluated if positron emission tomography (PET)/magnetic resonance imaging (MRI) elicited treatment mod...

    Felipe S. Furtado, Cristina R. Ferrone, Susanna I. Lee in Molecular Imaging and Biology (2021)

  11. No Access

    Article

    A Rare Case of Gallbladder Small Cell Carcinoma

    Norah E. Liang, Martin S. Taylor in Journal of Gastrointestinal Surgery (2021)

  12. No Access

    Chapter

    Survival After Resection for Pancreatic Cancer

    Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers. To achieve long term survival, surgical resection is essential in the treatment paradigm. While the morbidity and mortality of pa...

    Cristina R. Ferrone, Yurie Sekigami in Textbook of Pancreatic Cancer (2021)

  13. No Access

    Article

    Effects of laparoscopic vs open abdominal surgery on costs and hospital readmission rate and its effect modification by surgeons’ case volume

    Laparoscopy provides a minimally invasive alternative to open abdominal surgery. Current data describing its association with hospital readmission and costs in relation to surgeon laparoscopic case volume is l...

    Thomas H. Shin, Sabine Friedrich, Gabriel A. Brat, Maira I. Rudolph in Surgical Endoscopy (2020)

  14. Article

    Open Access

    A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma

    Patient-derived xenograft (PDX) mouse models of cancer have been recognized as better mouse models that recapitulate the characteristics of original malignancies including preserved tumor heterogeneity, lineag...

    Zhenyang Liu, Michael Ho-Young Ahn, Tomohiro Kurokawa in Journal of Translational Medicine (2020)

  15. Article

    Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Paloma Cejas, Yotam Drier, Koen M. A. Dreijerink, Lodewijk A. A. Brosens in Nature Medicine (2019)

  16. No Access

    Article

    Clinical impact of PET/MR in treated colorectal cancer patients

    The primary aim of the present study was to evaluate if PET/MR induced management changes versus standard of care imaging (SCI) in treated colorectal cancer patients. The secondary aim was to assess the stagin...

    Barbara J. Amorim, Theodore S. Hong in European Journal of Nuclear Medicine and M… (2019)

  17. No Access

    Article

    Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

    Most pancreatic neuroendocrine tumors (PNETs) do not produce excess hormones and are therefore considered ‘non-functional’13. As clinical behaviors vary widely and distant metastases are eventually lethal2,4, bi...

    Paloma Cejas, Yotam Drier, Koen M. A. Dreijerink, Lodewijk A. A. Brosens in Nature Medicine (2019)

  18. No Access

    Article

    Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?

    There is no consensus regarding the optimal surgical treatment for transplantable hepatocellular carcinoma (HCC) patients with well-compensated cirrhosis. Our aim was to compare outcomes between Child-Pugh A (...

    Theodoros Michelakos, Dimitrios Xourafas in Journal of Gastrointestinal Surgery (2019)

  19. Article

    Author Correction: High-fat diet enhances stemness and tumorigenicity of intestinal progenitors

    In Fig. 4e of this Article, the labels for ‘Control’ and ‘HFD’ were reversed (‘Control’ should have been labelled blue rather than purple, and ‘HFD’ should have been labelled purple rather than blue). Similarl...

    Semir Beyaz, Miyeko D. Mana, Jatin Roper, Dmitriy Kedrin, Assieh Saadatpour in Nature (2018)

  20. No Access

    Article

    Defective HLA class I antigen processing machinery in cancer

    Malignant transformation of cells is frequently associated with defective HLA class I antigen processing machinery (APM) component expression. This abnormality may have functional relevance, since it may have ...

    Lei Cai, Theodoros Michelakos, Teppei Yamada, Song Fan in Cancer Immunology, Immunotherapy (2018)

previous disabled Page of 3